Acquiring Company
Novacyt S.A
Acquired Company
Southern Cross Diagnostics Pty Ltd
SydneyBiotechnologyHealth CareHealth DiagnosticsBiotechnologyHealth CareDescription
Novacyt S.A. has agreed to acquire Southern Cross Diagnostics Pty Ltd to enhance its global growth. The acquisition, valued at an initial A$8.5m, will strengthen Novacyt's presence in the Australian clinical diagnostics market. Southern Cross’s founder will continue to lead post-acquisition, maintaining customer relationships. This transaction signifies a strategic pivot for Novacyt beyond COVID-19 testing.
Quick answer
Novacyt S.A is acquiring Southern Cross Diagnostics Pty Ltd, announced February 23, 2026.
- How much did Novacyt S.A pay for Southern Cross Diagnostics Pty Ltd?
- The deal value was not disclosed.
- What does Novacyt S.A do?
- Novacyt S.A. is an international molecular diagnostics company with a broad portfolio of integrated technologies and services.
- Where are Novacyt S.A and Southern Cross Diagnostics Pty Ltd based?
- Southern Cross Diagnostics Pty Ltd is based in Sydney, New South Wales, Australia.
- Who are the decision-makers at Novacyt S.A?
- Fundz holds 2 contacts at Novacyt S.A. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Health Diagnostics and Biotechnology
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Mainz Biomed N.V. Acquires Quantum Cyber to Enhance Cybersecurity Strategy (March 17, 2026)
- CoaguSense to acquire DOASENSE for testing expansion (March 23, 2026)
- Medimaps Group merges with Radiobotics for AI growth (March 2, 2026)
- Abbott Laboratories to acquire Exact Sciences (February 28, 2026)
- Abbott to acquire Exact Sciences approved by stockholders (February 20, 2026)
- Medtronic to acquire CathWorks for $585 million, $585M (February 3, 2026)
Who to call at Novacyt S.A, and when
When Novacyt S.A changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Novacyt S.A raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Novacyt S.A, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Novacyt S.A. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Novacyt S.A makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Southern Cross Diagnostics Pty Ltd?
Southern Cross Diagnostics Pty Ltd was acquired by Novacyt S.A. The deal was reported on February 23, 2026. Novacyt S.A. is an international molecular diagnostics company with a broad portfolio of integrated technologies and services. Novacyt S.A is privately held and operates in Biotechnology.
When did Novacyt S.A acquire Southern Cross Diagnostics Pty Ltd?
Novacyt S.A's acquisition of Southern Cross Diagnostics Pty Ltd was reported on February 23, 2026. Novacyt S.A. has agreed to acquire Southern Cross Diagnostics Pty Ltd to enhance its global growth. The acquisition, valued at an initial A$8.5m, will strengthen Novacyt's presence in the Australian clinical diagnostics market. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Southern Cross Diagnostics Pty Ltd do?
Southern Cross Diagnostics Pty Ltd is an Australian distributor of diagnostic and life science products. The company has established a profitable business model with revenues of approximately £6.7m and net profits of circa £0.8m in the last fiscal year. It is privately held, operating in Biotechnology, and is based in Sydney.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.